Market revenue in 2024 | USD 62.6 million |
Market revenue in 2030 | USD 129.2 million |
Growth rate | 12.8% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.34% in 2024. Horizon Databook has segmented the South Korea pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in South Korea is evolving rapidly, driven by an increasing number of clinical trials, innovative therapies, and technological advancements. According to WHO, in 2023.
the country recorded approximately 8,000 new pancreatic cancer cases, creating a growing demand for novel treatments. Major players such as AstraZeneca, Novartis AG, and Bristol-Myers Squibb Company are capitalizing on this opportunity, intensifying their research and development efforts.
Novartis AG is also making notable strides, with its targeted therapies gaining momentum, reflected an increase in patient enrollment for trials. These developments point to a shift toward more personalized and precision-based treatments in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Korea pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account